Computer-aided design of non-nucleoside inhibitors of HIV-1 reverse transcriptase
- 2 November 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (3), 663-667
- https://doi.org/10.1016/j.bmcl.2005.10.038
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- In Search of a Novel Anti-HIV Drug: Multidisciplinary Coordination in the Discovery of 4-[[4-[[4-[(1E)-2-Cyanoethenyl]-2,6-dimethylphenyl]amino]-2- pyrimidinyl]amino]benzonitrile (R278474, Rilpivirine)Journal of Medicinal Chemistry, 2004
- New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infectionsCurrent Opinion in Pharmacology, 2004
- Roles of Conformational and Positional Adaptability in Structure-Based Design of TMC125-R165335 (Etravirine) and Related Non-nucleoside Reverse Transcriptase Inhibitors That Are Highly Potent and Effective against Wild-Type and Drug-Resistant HIV-1 VariantsJournal of Medicinal Chemistry, 2004
- Prediction of drug solubility from structureAdvanced Drug Delivery Reviews, 2002
- Antiviral drug design: computational analyses of the effects of the L100I mutation for HIV-RT on the binding of NNRTIsBioorganic & Medicinal Chemistry Letters, 2001
- Validation of a Model for the Complex of HIV-1 Reverse Transcriptase with Sustiva through Computation of Resistance ProfilesJournal of the American Chemical Society, 2000
- Structural biology of HIV 1 1Edited by P. E. WrightJournal of Molecular Biology, 1999
- Models Which Explain the Inhibition of Reverse Transcriptase by HIV-1-Specific (Thio)carboxanilide Derivatives1Biochemical and Biophysical Research Communications, 1997
- Complexes of HIV-1 Reverse Transcriptase with Inhibitors of the HEPT Series Reveal Conformational Changes Relevant to the Design of Potent Non-Nucleoside InhibitorsJournal of Medicinal Chemistry, 1996
- Mechanism of Inhibition of HIV-1 Reverse Transcriptase by Nonnucleoside InhibitorsScience, 1995